GSK stock crumbled Friday after the FDA granted its blood cancer treatment, Blenrep, a narrower-than-expected approval.
Continue Reading
View Comments
GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short
Published 2 weeks ago
Oct 24, 2025 at 4:11 PM
Negative
Auto